[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
Makoto Asano, Junji Matsui, Murray J Towle, Jiayi Wu, Sharon McGonigle, Marc Hillairet DE Boisferon, Toshimitsu Uenaka, Kenichi Nomoto, Bruce A Littlefield
Eribulin is used in many countries to treat patients with advanced breast cancer or liposarcoma and exerts in vivo anticancer activity under monotherapy conditions against various human tumor xenograft models. Here, eribulin in combination with mechanistically different anticancer agents was evaluated.
Ref: Anticancer Res. 2018 Jun; 38(6):3375-3385. doi: 10.21873/anticanres.12604.